Related Experiment Video
Updated: Jul 9, 2026

Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins
Published on: January 18, 2019
Contrast-induced nephropathy
Antonio L Bartorelli1, Giancarlo Marenzi
1Centro Cardiologico Monzino - IRCCS, Institute of Cardiology, University of Milan, Milan, Italy. antonio.bartorelli@ccfm.it
Insights
Contrast-induced nephropathy (CIN) from radiological procedures is a major cause of kidney failure. Prevention is key as effective treatments for CIN are lacking, especially in patients undergoing percutaneous coronary interventions (PCI).
Area of Science:
- Nephrology
- Radiology
- Cardiology
Background:
- Radiological procedures using intravascular iodinated contrast media can cause contrast-induced nephropathy (CIN).
- CIN is a significant cause of hospital-acquired renal failure, associated with increased morbidity, mortality, and costs.
- Effective treatments for CIN are currently lacking, making prevention a critical strategy.
Purpose of the Study:
- To review the pathophysiology, risk factors, and clinical course of CIN.
- To examine recent studies on CIN prevention strategies.
- To discuss potential therapeutic interventions for CIN, particularly in the context of percutaneous coronary interventions (PCI).
Main Methods:
- Literature review of studies on contrast-induced nephropathy.
- Analysis of risk factors and clinical outcomes associated with CIN.
- Evaluation of current and emerging prevention and treatment strategies for CIN.
Main Results:
- Radiological procedures are a primary cause of CIN and hospital-acquired renal failure.
- Patients undergoing PCI are at high risk due to comorbidities.
- Prevention remains the primary focus due to limited treatment options.
Conclusions:
- CIN poses a significant threat in radiological and interventional procedures, especially PCI.
- Further research into effective prevention and treatment of CIN is crucial.
- Managing CIN risk factors and implementing preventive measures are essential for patient care.
Abstract:
Radiological procedures utilizing intravascular iodinated contrast media are being widely applied for both diagnostic and therapeutic purposes and represent one of the main causes of contrast-induced nephropathy (CIN) and hospital-acquired renal failure. Due to the lack of any effective treatment, prevention of this iatrogenic disease, which is associated with significant in-hospital and long-term morbidity and mortality and increased costs, is the key strategy. However, prevention of CIN continues to elude clinicians and is a major concern during percutaneous coronary interventions (PCI), as patients undergoing these procedures often have multiple comorbidities. The purpose of this article is to examine the pathophysiology, risk factors, and clinical course of CIN, as well as the most recent studies dealing with its prevention and potential therapeutic interventions, especially during PCI.
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Continuous Renal Replacement Therapy
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease I: Introduction
Nephrons
Acute Kidney Injury II: Pathophysiology
